2019
DOI: 10.1002/adfm.201908365
|View full text |Cite
|
Sign up to set email alerts
|

Amorphous Fe‐Based Nanoagents for Self‐Enhanced Chemodynamic Therapy by Re‐Establishing Tumor Acidosis

Abstract: Chemodynamic therapy (CDT) by introducing the Fenton-/Fenton-like reaction in an acidic and H 2 O 2 environment for toxic hydroxyl radical (•OH) generation, is a newly developed tumor-selective therapeutic. However, tumor acidosis, characterized by extracellular acidity (pH e ≈ 6.5) and intracellular alkalinity (pH i ≈ 7.2), undoubtedly confers a large chemical barrier for effective implementation of intracellular CDT and thus limits its functional activity and therapeutic efficacy. Here, the unique amorphous … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
121
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 152 publications
(122 citation statements)
references
References 36 publications
1
121
0
Order By: Relevance
“…Lately, catalytic reactions based on multivalent metal ions (such as Fe 2+ /Fe 3+ , Cu + /Cu 2+ , and Mn 2+ /Mn 4+ ) in nanozymes, which imitate the functions of natural enzymes, have displayed a conspicuous effect in accommodating TME and then improving the treatment outcome. [45][46][47][48] For instance, Zhang et al synthesized MnFe 2 O 4 @MOF (MOF = metal-organic framework) nanostructure with both catalase-like and GSH peroxidase-like activities, consecutively generating O 2 and depleting overexpressed GSH to modulate TME for achieving high antitumor effect. [49] Lin and co-workers prepared hollow mesoporous Cu 2 MoS 4 loaded glucose oxidase, which could effectively relieve tumor hypoxia and antioxidant capacity of tumor, showing improved antitumor efficacy combined with the photo therapy upon 808 nm laser irradiation.…”
mentioning
confidence: 99%
“…Lately, catalytic reactions based on multivalent metal ions (such as Fe 2+ /Fe 3+ , Cu + /Cu 2+ , and Mn 2+ /Mn 4+ ) in nanozymes, which imitate the functions of natural enzymes, have displayed a conspicuous effect in accommodating TME and then improving the treatment outcome. [45][46][47][48] For instance, Zhang et al synthesized MnFe 2 O 4 @MOF (MOF = metal-organic framework) nanostructure with both catalase-like and GSH peroxidase-like activities, consecutively generating O 2 and depleting overexpressed GSH to modulate TME for achieving high antitumor effect. [49] Lin and co-workers prepared hollow mesoporous Cu 2 MoS 4 loaded glucose oxidase, which could effectively relieve tumor hypoxia and antioxidant capacity of tumor, showing improved antitumor efficacy combined with the photo therapy upon 808 nm laser irradiation.…”
mentioning
confidence: 99%
“…Bu et al developed AFeNPs@CAI nanocomposites from amorphous iron nanoparticles (AFeNPs) loaded with carbonic anhydrase IX inhibitor (CAI). The release of CAI led to the accumulation of H + , which accelerated the Fenton reaction and amplified the oxidative damage of cells ( Chen et al, 2019 ). Fenton-like reactions catalyzed by Cu + are kinetically more favorable than those catalyzed by Fe 2+ under neutral and weakly acidic conditions.…”
Section: Inorganic Nanomaterials and Their Mechanisms Of Ros Generatimentioning
confidence: 99%
“…Unfortunately, these aforementioned organic agents suffer from some specific drawbacks such as low bioavailability and stability, short blood circulation time, and reluctant tumor‐accumulation, severely restricting the efficiency of SDT (Chen et al, 2017; Paris & Vallet‐Regí, 2020; Yue et al, 2019). To overcome these obstacles, MSNs are desirable organic sonosensitizers reservoirs due to the large surface area and tunable pore size, high biocompatibility, and rapid biodegradation (Chen et al, 2019; Knezevic & Kaluderovic, 2017; Zhou et al, 2020). Li, Kwon, et al (2018) constructed a targeted biodegradable mesoporous sonosensitizer‐relevant nanosystem (DOX@HMONs‐PpIX‐RGD) for synergistic SDT/chemotherapy (Figure 3a).…”
Section: Energy‐converting Biomaterials For Cancer Therapymentioning
confidence: 99%